ArticleTranslational behavioral medicine2018

Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.

Lisa G Aspinwall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.